We report a critical role of IL-33/ST2 signaling as experimental AD in IL-33- and ST2−/− mice was drastically reduced with only minor reduction in IL-1αβ−/− mice, but no difference in IL-36 R−/− and IL-36Ra−/− mice. This evidence concerns the gene IL33 and Alzheimer disease.